- Home
- AVTX vs INO Comparison
AVTX vs INO Comparison
Compare AVTX & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- INO
- Stock Information
- Founded
- AVTX 2011
- INO 1979
- Country
- AVTX United States
- INO United States
- Employees
- AVTX N/A
- INO N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- AVTX Health Care
- INO Health Care
- Exchange
- AVTX Nasdaq
- INO Nasdaq
- Market Cap
- AVTX 88.4M
- INO 75.4M
- IPO Year
- AVTX 2015
- INO 1998
- Fundamental
- Price
- AVTX $8.44
- INO $2.24
- Analyst Decision
- AVTX Strong Buy
- INO Buy
- Analyst Count
- AVTX 4
- INO 6
- Target Price
- AVTX $33.00
- INO $17.00
- AVG Volume (30 Days)
- AVTX 36.6K
- INO 739.9K
- Earning Date
- AVTX 03-28-2025
- INO 03-05-2025
- Dividend Yield
- AVTX N/A
- INO N/A
- EPS Growth
- AVTX N/A
- INO N/A
- EPS
- AVTX N/A
- INO N/A
- Revenue
- AVTX $820,000.00
- INO $203,413.00
- Revenue This Year
- AVTX N/A
- INO N/A
- Revenue Next Year
- AVTX N/A
- INO $1,970.14
- P/E Ratio
- AVTX N/A
- INO N/A
- Revenue Growth
- AVTX N/A
- INO N/A
- 52 Week Low
- AVTX $4.24
- INO $1.74
- 52 Week High
- AVTX $34.46
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- AVTX 57.77
- INO 54.46
- Support Level
- AVTX $6.81
- INO $1.82
- Resistance Level
- AVTX $8.00
- INO $2.31
- Average True Range (ATR)
- AVTX 0.56
- INO 0.14
- MACD
- AVTX 0.03
- INO 0.05
- Stochastic Oscillator
- AVTX 81.99
- INO 83.17
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.